Cite
HARVARD Citation
Honing, J. et al. (n.d.). CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. Radiotherapy and oncology. 117 (1), pp. 152-158. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Honing, J. et al. (n.d.). CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. Radiotherapy and oncology. 117 (1), pp. 152-158. [Online].